loadpatents
name:-0.029710054397583
name:-0.019401073455811
name:-0.0015029907226562
HOWSHAM; Catherine Patent Filings

HOWSHAM; Catherine

Patent Applications and Registrations

Patent applications and USPTO patent grants for HOWSHAM; Catherine.The latest application filed is for "pyridine and pyrazine derivative for the treatment of cf".

Company Profile
1.29.36
  • HOWSHAM; Catherine - Horsham GB
  • Howsham; Catherine - West Sussex GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pyridine and Pyrazine Derivative for the Treatment of CF
App 20210228554 - BAETTIG; Urs ;   et al.
2021-07-29
Pyridine and Pyrazine Derivative for the Treatment of CF
App 20190262324 - BAETTIG; Urs ;   et al.
2019-08-29
Pyridine and pyrazine derivative for the treatment of CF
Grant 10,117,858 - Baettig , et al. November 6, 2
2018-11-06
Pyrazolo [3,4-d] Pyrimidine Derivatives Useful To Treat Respiratory Disorders
App 20180125849 - Bloomfield; Graham Charles ;   et al.
2018-05-10
Pyridine and pyrazine derivative for the treatment of CF
Grant RE46,757 - Baettig , et al. March 20, 2
2018-03-20
Pyrazine Derivatives As Enac Blockers
App 20170143705 - BHALAY; Gurdip ;   et al.
2017-05-25
Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
Grant 9,643,983 - Bhalay , et al. May 9, 2
2017-05-09
Pyridine and Pyrazine derivative for the Treatment of CF
App 20170071919 - BAETTIG; Urs ;   et al.
2017-03-16
Pyrazine derivatives as ENaC blockers
Grant 9,522,149 - Bhalay , et al. December 20, 2
2016-12-20
Pyrazolo [3,4-d] Pyrimidine Derivatives Useful To Treat Respiratory Disorders
App 20160303132 - Bruce; Ian ;   et al.
2016-10-20
Pyridine and pyrazine derivative for the treatment of CF
Grant 9,365,552 - Baettig , et al. June 14, 2
2016-06-14
Treating Diseases Mediated By Blockade Of The Epithelial Sodium Channel With Pyrazine-2-carboxamide Derivatives
App 20160068546 - BHALAY; Gurdip ;   et al.
2016-03-10
Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
Grant 9,139,586 - Bhalay , et al. September 22, 2
2015-09-22
Pyrazine Derivatives As Enac Blockers
App 20150224098 - BHALAY; Gurdip ;   et al.
2015-08-13
N-substituted heterocyclyl carboxamides
Grant 9,056,867 - Bala , et al. June 16, 2
2015-06-16
Pyrazine derivatives as ENaC blockers
Grant 9,050,339 - Bhalay , et al. June 9, 2
2015-06-09
Pyridine and Pyrazine derivative for the Treatment of CF
App 20150045364 - BAETTIG; Urs ;   et al.
2015-02-12
Pyrazolo [3,4-D] pyrimidine derivatives useful to treat respiratory disorders
Grant 8,901,134 - Bloomfield , et al. December 2, 2
2014-12-02
N-Substituted Heterocyclyl Carboxamides
App 20140323485 - Bala; Kamlesh Jagdis ;   et al.
2014-10-30
Pyrazine compounds as PI3 kinase inhibitors
Grant 8,846,687 - Bruce , et al. September 30, 2
2014-09-30
Crystalline form
Grant 8,809,340 - Howsham , et al. August 19, 2
2014-08-19
Treating Diseases Mediated By Blockade Of The Epithelial Sodium Channel With Pyrazine-2-carboxamide Derivatives
App 20140171421 - Bhalay; Gurdip ;   et al.
2014-06-19
Pyridine and Pyrazine derivative for the Treatment of CF
App 20140135329 - BAETTIG; Urs ;   et al.
2014-05-15
Pyrazine Derivatives As Enac Blockers
App 20140113914 - BHALAY; Gurdip ;   et al.
2014-04-24
Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
Grant 8,697,687 - Bhalay , et al. April 15, 2
2014-04-15
3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases
Grant 8,664,228 - Collingwood , et al. March 4, 2
2014-03-04
Pyrazolo [3,4-D] Pyrimidine Derivatives Useful to Treat Respiratory Disorders
App 20140051698 - Bruce; Ian ;   et al.
2014-02-20
Novel Crystalline Form
App 20130345239 - Howsham; Catherine ;   et al.
2013-12-26
Pyridine and pyrazine derivative for the treatment of CF
Grant 8,476,269 - Baettig , et al. July 2, 2
2013-07-02
Pyrazine derivatives as enac blockers
Grant 8,372,845 - Bhalay , et al. February 12, 2
2013-02-12
Organic Compounds
App 20130012500 - BHALAY; Gurdip ;   et al.
2013-01-10
Pyridine and Pyrazine Derivative for the Treatment of CF
App 20120277232 - BAETTIG; Urs ;   et al.
2012-11-01
Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
Grant 8,268,834 - Bruce , et al. September 18, 2
2012-09-18
Organic compounds
Grant 8,263,585 - Bruce , et al. September 11, 2
2012-09-11
Organic Compounds
App 20120214800 - Bruce; Ian ;   et al.
2012-08-23
Pyridine and pyrazine derivative for the treatment of CF
Grant 8,247,436 - Baettig , et al. August 21, 2
2012-08-21
Pyrazine derivatives as ENAC blockers
Grant 8,236,808 - Collingwood , et al. August 7, 2
2012-08-07
Pyrazine Derivatives As Enac Blockers
App 20120071479 - Bhalay; Gurdip ;   et al.
2012-03-22
Pyrazine-2-carboxamide derivatives to treat diseases mediated by blockade of the epithelial sodium channel
Grant 8,039,472 - Bhalay , et al. October 18, 2
2011-10-18
Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
App 20110237572 - Bhalay; Gurpid ;   et al.
2011-09-29
Pyridine and Pyrazine derivative for the Treatment of CF
App 20110230483 - BAETTIG; Urs ;   et al.
2011-09-22
Organic Comopunds
App 20110201625 - Collingwood; Stephen Paul ;   et al.
2011-08-18
3,5-diamino-6-chloro-pyrazine-2-carboxylic Acid Derivatives And Their Use As Epithelial Sodium Channel Blockers For The Treatment Of Airway Diseases
App 20110059989 - Collingwood; Stephen Paul ;   et al.
2011-03-10
Organic Compounds
App 20100130506 - BHALAY; Gurdip ;   et al.
2010-05-27
Organic compounds
App 20090239847 - BRUCE; Ian ;   et al.
2009-09-24
Organic Compounds
App 20090163463 - Bruce; Ian ;   et al.
2009-06-25
Pyrazolo [3,4-D] Pyrimidine Derivatives Useful to Treat Respiratory Disorders
App 20090131457 - Bruce; Ian ;   et al.
2009-05-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed